EXTENSIVE STAGE LUNG SMALL CELL CARCINOMA
Clinical trials for EXTENSIVE STAGE LUNG SMALL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new EXTENSIVE STAGE LUNG SMALL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for EXTENSIVE STAGE LUNG SMALL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New immune drug tested as First-Line attack on aggressive lung cancer
Disease control Recruiting nowThis study is testing a new drug called tarlatamab as the very first treatment for people with extensive-stage small cell lung cancer, an aggressive form of the disease. The drug works by guiding the body's own immune cells to attack the cancer. Researchers want to see if this ap…
Matched conditions: EXTENSIVE STAGE LUNG SMALL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Asrar Alahmadi • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Double attack on tough lung cancer: radiation joins forces with immune therapy
Disease control Recruiting nowThis study is for people with extensive-stage small cell lung cancer that has spread. It tests if adding a targeted course of radiation therapy to ongoing immunotherapy (atezolizumab) can keep the cancer from growing or spreading for a longer time compared to continuing immunothe…
Matched conditions: EXTENSIVE STAGE LUNG SMALL CELL CARCINOMA
Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New drug combo aims to keep aggressive lung cancer at bay
Disease control Recruiting nowThis study is for people with extensive-stage small cell lung cancer that has spread. It tests whether adding a new oral drug called iadademstat to standard immunotherapy maintenance treatment can help control the cancer and prevent it from growing for a longer period. The first …
Matched conditions: EXTENSIVE STAGE LUNG SMALL CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC
-
New combo therapy tested to fight tough lung Cancer's return
Disease control Recruiting nowThis study is testing if a combination of two drugs can help control advanced small cell lung cancer that has returned or spread after initial treatment. It will involve about 56 adults whose cancer has progressed after standard chemo-immunotherapy. The goal is to see if adding a…
Matched conditions: EXTENSIVE STAGE LUNG SMALL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Dwight Owen • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC
-
Antiviral drug joins fight against aggressive lung cancer
Disease control Recruiting nowThis study is testing whether adding an oral antiviral drug called lamivudine to standard chemotherapy and immunotherapy can better control extensive stage small cell lung cancer. The goal is to see if lamivudine can help prevent the cancer from becoming resistant to treatment, w…
Matched conditions: EXTENSIVE STAGE LUNG SMALL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Mar 13, 2026 15:06 UTC
-
New trial matches lung cancer patients to personalized drug cocktails
Disease control Recruiting nowThis Phase 2 trial tests whether personalized maintenance treatments can better control extensive stage small cell lung cancer. Researchers will analyze tumor tissue from 900 patients to match them to one of three treatment groups based on their cancer's specific features. After …
Matched conditions: EXTENSIVE STAGE LUNG SMALL CELL CARCINOMA
Phase: PHASE2 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated Mar 06, 2026 15:37 UTC
-
New combo therapy tested for Tough-to-Treat lung cancer
Symptom relief Recruiting nowThis early-stage study aims to find out if it is safe to give palliative radiation therapy at the same time as a cancer drug called lurbinectedin. The trial is for adults with extensive stage small cell lung cancer that has spread and worsened after initial chemotherapy. Research…
Matched conditions: EXTENSIVE STAGE LUNG SMALL CELL CARCINOMA
Phase: PHASE1 • Sponsor: Emory University • Aim: Symptom relief
Last updated Mar 31, 2026 12:12 UTC